Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ABSTRACT


01 enero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Baseline anemia and its impact on midterm outcome after transcatheter aortic valve implantation

Moritz Seiffert MD, Lenard Conradi MD, Andreas Gutwein BSC, Gerhard Schön MSC, Florian Deuschl MD, Niklas Schofer MD, Nina Becker BSC, Johannes Schirmer MD, Hermann Reichenspurner MD, PhD, Stefan Blankenberg MD, Hendrik Treede MD, Ulrich Schäfer MD

Background: Anemia is linked to impaired outcome in patients with cardiovascular diseases. We sought to characterize the impact of baseline anemia on mid-term outcome after transcatheter aortic valve implantation (TAVI).

01 enero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Transfemoral aortic valve implantation of Edwards SAPIEN 3 without predilatation

Won‐Keun Kim MD, Fabien Praz MD, Johannes Blumenstein MD, Christoph Liebetrau MD, Luise Gaede MD, Arnaud Van Linden MD, Christian Hamm MD, PhD, Thomas Walther MD, PhD, Stephan Windecker MD, PhD, Helge Möllmann MD, PhD

Objectives: The purpose of the present study was to investigate whether transfemoral implantation of the balloon‐expandable Edwards SAPIEN 3 device without prior balloon valvuloplasty is feasible.

01 enero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Off‐label use of the amplatzer ductal occluder II additional size for percutaneous treatment of acute aortic occlusion in a baby

G. Ferraro MD, D. Marini MD, G. Agnoletti MD, PhD

We describe the case of a 5‐month‐old baby with a pro‐coagulative condition, referred for rapid atrial tachycardia. At echocardiography we found a large free‐floating atrial thrombus that spontaneously embolized into the descending aorta and produced acute sub‐renal occlusion. Aorta and iliac vessels were cleared using the ADO II additional sizes device. © 2016 Wiley Periodicals, Inc.

01 enero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Antiplatelet therapy and outcome in patients undergoing surgery following coronary stenting: Results of the surgery after stenting registry

Roberta Rossini MD, PhD, Dominick J. Angiolillo MD, PhD, Giuseppe Musumeci MD, Davide Capodanno MD, PhD, Maddalena Lettino MD, Daniela Trabattoni MD, Annarita Pilleri MD, Paolo Calabria MD, Paola Colombo MD, PhD, Paola Bernabò MD, Marco Ferlini MD, Marco Ferri MD, Giuseppe Tarantini MD, PhD, Stefano De Servi MD, Stefano Savonitto MD

Objectives: The aim of the present study was to define the feasibility and clinical impact of complying with national consensus recommendations on perioperative management of antiplatelet therapy in patients with coronary stents undergoing cardiac and noncardiac surgery.

01 enero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. A novel maneuver to facilitate retrograde wire externalization during retrograde chronic total occlusion percutaneous coronary intervention

Mauro Carlino MD, Lorenzo Azzalini MD, PhD, MSc, Antonio Colombo MD

Background: Although the retrograde approach has improved the success rate and procedural efficiency of chronic total occlusion (CTO) percutaneous coronary intervention (PCI), it can still be challenging and time‐consuming. We introduce a novel technique that aims to facilitate the critical step of retrograde wire externalization during reverse controlled antegrade and retrograde tracking and dissection (CART), which we named DRAFT (Deflate, Retract and Advance into the Fenestration Technique).

01 enero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. The Glider registry

Gioel Gabrio Secco MD, Harald Rittger MD, Stefan Hoffmann MD, Gert Richardt MD, Mohamed Abdel‐Wahab MD, Holger Reinecke MD, Chaim Lotan MD, Gerald Werner MD, Horst Sievert MD, Nicolas Foin MSC, Carlo Di Mario MD

Background: Provisional stenting of the side‐branch (SB) is the universally accepted gold standard while there is still controversy on the usefulness of routine dilatation of the SB ostium. Recrossing the struts of a previously deployed stent with a wire and a balloon can prove challenging and is occasionally unsuccessful, mainly because the balloon tip hits a stent strut. This prospective multicenter international registry tested the crossing ability procedural results of a new‐dedicated ultrashort balloon specifically designed for side branch dilatation (Glider, TriReme Medical, Pleasanton, CA, USA).

01 enero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Severe mitral regurgitation and biventricular heart failure successfully treated with biventricular percutaneous axial flow pumps as a bridge to mitral valve surgery

Brian M. Renard MD, Ivan D. Hanson MD, James A. Goldstein MD

Prompt recognition of acute right ventricular failure is essential in order to provide timely hemodynamic support. We report a case of a patient with severe mitral regurgitation complicated by cardiogenic shock that failed to improve with left ventricular support alone. The recognition of concomitant right ventricular failure led to the addition of a right ventricular support device, resulting in dramatic hemodynamic improvement. © 2016 Wiley Periodicals, Inc.

01 enero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Sex‐based differences in outcomes with bivalirudin or unfractionated heparin for transcatheter aortic valve replacement: Results from the BRAVO‐3 randomized trial

A. Asgar MD, J. Chandrasekhar MBBS, G. Mikhail MD, J. Webb MD, T. Lefèvre MD, C. Tamburino MD, D. Hildick‐Smith MD, R. Hambrecht MD, E. Van Belle MD, J. Widder MD, N. Dumonteil MD, U Hink MD, R. Jeger MD, A. Linke MD, E. Deliargyris MD, P. Gao MS R. Mehran MD, C. Hengstenberg MD, P. Anthopoulos MD, G. Dangas MD, PhD

Background: Women comprise almost 50% of patients undergoing transcatheter aortic valve replacement (TAVR) and previous studies have indicated higher rates of procedural complications and bleeding in women compared to men. It is unknown whether men and women demonstrate a differential response to bivalirudin versus unfractionated heparin (UFH) in TAVR. We sought to evaluate outcomes by sex and type of anticoagulant from the Bivalirudin Versus Heparin Anticoagulation in Transcatheter Aortic Valve Replacement (BRAVO‐3) trial of transfemoral TAVR.

01 enero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. How to deal with atrial septal defect closure from right internal jugular vein: Role of venous‐arterial circuit for sizing and over‐the‐wire device implantation

Gianfranco Butera MD, PhD, Nicusor Lovin MD, Domenica Paola Basile MD

Secundum atrial septum defect (ASD) is the most common congenital heart disease. It is usually treated by a transcatheter approach using a femoral venous access. In case of bilateral femoral vein occlusion, the internal jugular venous approach for ASD closure is an option, in particular in cases where ASD balloon occlusion test and sizing is needed. Here, we report on a new technique for ASD closure using a venous‐arterial circuit from the right internal jugular vein to the femoral artery. Two patients (females, 4 and 10 years of age) had occlusion of both femoral veins because of a previous history of pulmonary atresia and intact ventricular septum, for which they underwent percutaneous radiofrequency perforation and balloon angioplasty. These subjects needed balloon occlusion test of a residual ASD to size the hole and to check for hemodynamic suitability to ASD closure. After performing a venous‐arterial circuit, a 24 mm St Jude ASD sizing balloon catheter was advanced over the circuit and the defect closed for 15 min to check hemodynamics and size the defect. ASD was closed is hemodinamically suitable. This technique was safe and reliable.

01 enero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Circumflex coronary artery injury after mitral valve surgery: A report of four cases and comprehensive review of the literature

Nick Hiltrop MD, Johan Bennett MD, Walter Desmet MD, PhD

As the LCx is closely related to the mitral valve annulus, it is susceptible to perioperative injury. Various underlying mechanisms, predisposing factors, and therapeutic strategies have been suggested but disagreement exists. Using a MeSH terms‐based PubMed search, 44 cases of mitral valve surgery‐related LCx injury were detected, including our 4 cases. We provide a comprehensive review of current knowledge regarding mitral valve surgery‐related left circumflex coronary artery (LCx) injury. Preoperative coronary angiography was performed in 55% (n = 24). Coronary abnormalities were present in 11% (n = 5). Coronary dominance was reported in 73% (n = 32), predominantly showing left (69%, n = 22) or balanced (19%, n = 6) circulations. Right coronary dominance was present in 12% (n = 4). Ischemia was detected in the perioperative or early postoperative phase in 86% (n = 30). Delayed symptoms were present in 14% (n = 5). Echocardiography demonstrated new regional wall motion abnormalities in 80% (n = 24), but was negative in 20% (n = 6) despite coronary compromise. Electrocardiography showed myocardial ischemia in 97% (n = 34), including regional ST‐segment elevations in 68% (n = 23). Primary treatment was surgical in 42% (n = 15) and percutaneous in 58% (n = 21), reporting success ratios of 87% (n = 13) and 81% (n = 17), respectively. We confirm an augmented risk of mitral valve surgery‐related LCx injury in balanced or left‐dominant coronary circulations. Preoperative knowledge of coronary anatomy does not preclude LCx injury. An anomalous LCx arising from the right coronary cusp was identified as a possible specific high‐risk entity. Electrocardiographic monitoring and intraoperative echocardiography remain paramount to ensure a timely diagnosis and treatment.

01 enero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Mechanical thrombectomy using the Solitaire stent in a left main coronary artery: A novel approach to coronary thrombus retrieval

Carlos E. Uribe MD, Mauricio Zuñiga MD, Camilo Madrid MD

The Solitaire stent is a self‐expanding nitinol, fully retrievable stent that was originally designed for applications in cerebral circulation. Expanded indications for its use in mechanical embolectomy during acute ischemic stroke have proven safe and effective. Herein, we describe a novel use of this stent to perform a mechanical thrombectomy of a large left main coronary artery thrombus.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.